(株)ミズホメディーの貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4595/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/03/29 | 日証協 | 182,700株 | -3.55% | 35,700株 | +3933.9% | 199,876株 | -4.67% | 6,902株 | +228.67% |
2019/03/22 | 日証協 | 189,415株 | -6.28% | 885株 | -41% | 209,676株 | -2.92% | 2,100株 | -94.32% |
2019/03/15 | 日証協 | 202,115株 | -5.51% | 1,500株 | -93.72% | 215,976株 | -8.47% | 37,000株 | +128.4% |
2019/03/08 | 日証協 | 213,900株 | +2% | 23,880株 | +69.51% | 235,961株 | -4.38% | 16,200株 | +14.33% |
2019/03/01 | 日証協 | 209,700株 | +2.19% | 14,088株 | -55.7% | 246,766株 | -0.65% | 14,170株 | -45.99% |
2019/02/22 | 日証協 | 205,200株 | +11.46% | 31,800株 | +283.13% | 248,388株 | +5.71% | 26,234株 | +60.94% |
2019/02/15 | 日証協 | 184,100株 | -2.64% | 8,300株 | -34.65% | 234,976株 | -0.51% | 16,300株 | -32.92% |
2019/02/08 | 日証協 | 189,100株 | -3.72% | 12,700株 | -29.44% | 236,176株 | -9.68% | 24,300株 | -54.41% |
2019/02/01 | 日証協 | 196,400株 | +1.66% | 18,000株 | +102.25% | 261,481株 | +3.24% | 53,300株 | +39.51% |
2019/01/25 | 日証協 | 193,200株 | -13.17% | 8,900株 | -44.03% | 253,281株 | -8.33% | 38,206株 | -24.21% |
2019/01/18 | 日証協 | 222,500株 | -11.78% | 15,900株 | -55.59% | 276,286株 | -2.33% | 50,410株 | +10.38% |
2019/01/11 | 日証協 | 252,200株 | -43.37% | 35,800株 | 0% | 282,891株 | -38.62% | 45,669株 | +33.54% |
2019/01/04 | 日証協 | 445,364株 | +6.45% | 0株 | -100% | 460,876株 | +4.14% | 34,200株 | -88.93% |
2018/12/28 | 日証協 | 418,364株 | +121.12% | 266,064株 | +1185.33% | 442,564株 | +99.64% | 308,900株 | +295.52% |
2018/12/21 | 日証協 | 189,200株 | +7.56% | 20,700株 | +989.47% | 221,680株 | +8.52% | 78,100株 | +120.62% |
2018/12/14 | 日証協 | 175,900株 | -0.06% | 1,900株 | +533.33% | 204,280株 | +1.69% | 35,400株 | +405.71% |
2018/12/07 | 日証協 | 176,000株 | -5.12% | 300株 | -97.3% | 200,880株 | -4.2% | 7,000株 | -82.46% |
2018/11/30 | 日証協 | 185,500株 | +3.86% | 11,100株 | +38.75% | 209,680株 | -4.46% | 39,915株 | -21.12% |
2018/11/22 | 日証協 | 178,600株 | +1.59% | 8,000株 | +66.67% | 219,465株 | -10.66% | 50,600株 | -20.19% |
※株式分割は考慮していませんのでご注意ください。
Page Top